异双Schiff碱及其稀土配合物的合成、机理与波谱

利用2,6-二氨基己酸(赖氨酸)具有两端不对称结构的－NH~2基,合成了一端与水杨醛,另一端与2,4-二羟基苯甲醛缩合形成空间结构不对称的异双Schiff碱及其与稀土元素配合物。以元素分析、热分析、摩尔电导、红外光谱、EPR以及^1HNMR,^1^3C-^1HCOSY谱、固体高分辨^1^3C谱等表征,研究了这类不对称Schiff碱的形成机理和配位方式。     

石英片基表面联吡啶钌配合物的合成与表征

将6-溴-2,2'∶6',2"-三联吡啶转化为6-甲酰基-2,2'∶6',2"-三联吡啶, 再将其与表面组装有氨基硅氧烷的石英片基反应, 使甲酰基与片基表面的氨基反应生成Schiff碱型化合物, 在氨基化片基表面成功地固定6-甲酰基-2,2'∶6',2"-三联吡啶及相应的钌配合物, 并用紫外-可见吸收光谱及光电子能谱(XPS)检测联吡啶及相应钌配合物的组装过程.     

New superior bioactive metal complexes of ligand with N,O donor atoms bearing sulfadiazine moiety: Physicochemical study and thermal behavior for chemotherapeutic application

Sulfadiazine is a drug famous for its anti-inflammatory, antimicrobial, and antitumor effects. Remarkably, its biological activity can be further enhanced upon incorporating a suitable metal ion. However, these metal-comprising complexes are not widely available. In the current study, a sulfadiazine Schiff base derivative was exploited as a ligand for synthesizing new complexes utilizing Cu(II), Co(II), Ni(II), Fe(III), and Cr(III) metals. The structural and analytical characteristics of the ligand and the newly prepared complexes were elucidated using various spectral and thermal investigations. Also, the biological activity of the ligand and the metal complexes, including the cytotoxic effect on normal cells and on liver malignant cells and the antimicrobial activity, was examined. The infrared spectra demonstrated that the ligand coordinated to all the added metal ions in a neutral form. It behaved in a bidentate manner in all mononuclear complexes. The new complexes exhibited octahedral geometry. Evaluating the biological activities revealed that the ligand and its novel metal-containing complexes had moderate antimicrobial activity, while the metal complexes, especially those comprising of Cr(III), Fe(III), and Cu(II), displayed a superior chemotherapeutic effect on HepG2 cell line in comparison to the ligand with very week or rare cytotoxic effects on normal human cells. Efficiently, new sulfadiazine Schiff base derivative-containing metal complexes with enhanced therapeutic potential were manufactured and could be applied on experimental models for the treatment of various types of infections and malignancies.     

Recent advances in anticancer ruthenium Schiff base complexes

Nowadays in cancer treatment, both metal complexes and organic molecules are being widely used. Current years have seen a surge of interest in the application of organometallic compounds to treat cancer and other diseases. Undeniably, the unique properties of organometallic compounds, intermediate between those of classical inorganic and organic materials, provide new opportunities in the field of medicinal chemistry. Since the discovery of cisplatin, many transition metal complexes have been synthesized and assayed for anticancer activity. In recent years, ruthenium-based Schiff base complexes have emerged as promising antitumor and antimetastatic agents with potential uses in treatment of platinum-resistant tumors or as alternatives to platinum-based chemotherapy. Advantages of utilizing ruthenium complexes in drug development include reliable methods of synthesizing stable complexes; the ability to tune ligand affinities, electron transfer and substitution rates, and reduction potentials; and an increasing knowledge of the biological effects of such complexes. This great expansion of ruthenium-based Schiff base complexes is mainly due to the unique ability of the ruthenium core to permit multiple oxidation states, hence versatile electron-transfer pathways, and because of the ease of preparation with versatile and variable-denticity Schiff base ligands. This review aims to bring the reader up to date with the more recent Ru(II)/(III)-based Schiff base complexes that have been synthesized and investigated for their cytotoxicity.     

Metal complexes of biological active 2-aminothiazole derived ligands

The most imperative outcomes of extensive sterdies (synthesis, spectral, structural characterization and biological applications) of metal complexes with thiazole derived ligands are reviewed. A large number of coordination compounds are known but still there is a need of new compounds to develop various efforts in different fields for biomedical applications. The synthesis of Schiff base ligands is very important, and it has recently drawn the attention of numerous research groups, making this area constantly evolve. Authors are also synthesizing some novel biologically potent ligands and their unique complexes and complexes found more biological active agents than that of ligands against bacteria, fungi and herbs. Highlights: Schiff bases and their metal chelates catalyze reactions; Schiff bases derived from sulfane thiadiazole show toxicities against insects; Schiff bases of thiadiazole have good plant regulator activity; Phenyl ring attached to the thiazole group showed interesting structure activity.     

Synthesis,spectral studies,thermal behavior,and antibacterial activity of Ni(Ⅱ),Cu(Ⅱ),and Zn(Ⅱ) complexes with an ONO tridentate Schiff base

Three new transition metal complexes have been synthesized with a Schiff base,3-(2-hydroxy-5-chlorophenylimino)-l,3- diphenylpropen-1-one.In all complexes Schiff base is completely deprotonated and coordinated to metal as tridentate ligand via phenolic and enolic oxygens and imine nitrogen.Thermal decomposition of the complexes has been studied by thermogravimetry. The in vitro antibacterial activity of Schiff bases and their complexes has been evaluated and compared with the standard drugs.     

Synthesis, characterization and computational studies of zinc(II)-halide complexes with a bidentate schiff base ligand (2,5-MeO-ba)2En: The crystal structure of (2,5-MeO-ba)2En

In this study four coordinated complexes of zinc(II) halides with a new symmetrical bidentate Schiff base ligand (2,5-MeO-ba)₂En are synthesized and characterized. The metal to ligand ratio of the complexes is found to be 1:1 with the formula of Zn((2,5-MeO-ba)₂En)X₂ (X = Cl (1), Br (2), I (3)). The crystal structure of the Schiff base ligand (2,5-MeO-ba)₂En is determined by X-ray crystallography from single crystal data. Also, the optimized geometries of the Schiff base ligand (2,5-MeO-ba)₂En and its zinc(II) complexes are calculated using the density functional theory method (B3LYP/6-31G). The obtained structural parameters of (2,5-MeO-ba)₂En are in agreement with the experimental data.     

Synthesis,Characterization, and Thermal Investigation of Some Metal Complexes Containing Polydentate ONO-Donor Heterocyclic Schiff Base Ligand

Cu(II), Co(II), Ni(II), and Zn(II) metal complexes with new heterocyclic Schiff base derived from 1-amino-5-benzoyl-4-phenyl-1H-pyrimidine-2-one and 3-methoxysalicylaldehyde have been synthesized and characterized on the basis of elemental analyses, electronic, IR, and ¹H NMR spectra, and also by aid of molar conductivity measurements, magnetic moment measurements, and thermogravimetric analyses. It has been found that the Schiff base behaves as a neutral bidentate (NO) and tridentate (ONO) ligand forming chelates with 1 : 2 (metal : ligand) stoichiometry. Octahedral configuration is suggested for metal complexes. The conductivity data for the Ni(II) complexes are consistent with those expected for a 1 : 2 electrolyte.     

Syntheses, characterization, antimicrobial and genotoxic activities of new Schiff bases and their complexes

Two new Schiff base ligands (L¹, L²) have been prepared from the reaction of 2,6-diacetylpyridine and 2-pyridinecarboxyaldehyde with 4-amino-2,3-dimethyl-1-phenyl-3-pyrozolin-5-on, and their Co(II), Cu(II), Ni(II), Mn(II), and Cr(III) metal complexes have also been prepared. The complexes are formed by coordination of N and O atoms of the ligands. Their structures were characterized by physico-chemical and spectroscopic methods. The analytical data shows that the metal to ligand ratio in the Schiff base complexes is 1:2. The Schiff base ligands and all complexes were evaluated for their in vitro antibacterial and antifungal activities by the disc diffusion method. In addition, the genotoxic properties of the ligands were studied.     

New metal(II) complexes with ceftazidime Schiff base

Complexes of Co(II), Ni(II) and Cu(II) with the Schiff base (LH) derived from ceftazidime and salicylaldehyde were synthesized. The proposed structures of the new metal complexes based on the results of elemental analyses, molar conductivity, IR, DRUV and ¹H NMR spectra, effective magnetic moment and thermal analysis were discussed. The surface morphology of Schiff base and metal complexes was studied by SEM. The composition of the metal complexes was ML₂, where L is the deprotonated Schiff base ligand and M = Co(II), Ni(II) and Cu(II). IR spectral data indicated the Schiff base ligand being bidentately coordinated to the metallic ions with N and O atoms from azomethine and phenolic groups. All the complexes have square-planar geometry and are nonelectrolytes. The thermal analysis recorded that TG, DTG, DTA and DSC experiments confirmed the assigned composition and gave information about the thermal stability of complexes in dynamic air atmosphere. Theoretical investigation of the molecular structure of Schiff base ligand and its complexes was studied using programs dedicated to chemical modeling and quantomolecular calculation of chemical properties. The newly synthesized complexes were tested for in vitro antibacterial activity against selected Gram-negative and Gram-positive bacterial strains, and they exhibited an antibacterial activity superior to that of the Schiff base ligand.     

Biomolecular docking,antimicrobial and cytotoxic studies on new bidentate schiff base ligand derived metal (II) complexes

Three new metal complexes [Cu(L)₂] (1), [Co(L)₂] (2) and [Zn(L)₂] (3) have been prepared by the reaction of hydrated salts of metal (II) acetate with new Schiff base ligand HL, [2‐((4‐(dimethylamino)phenylimino)methyl)‐4,6‐di‐t‐butylphenol] and characterized by different physico‐chemical analyses such as elemental analysis, single XRD, ¹H NMR, FTIR and UV–Vis spectroscopic techniques. Their biomolecular docking, antimicrobial and cytotoxicity studies have also been demonstrated. The proposed structure of Schiff base ligand HL and complex 2 are confirmed by Single crystal X‐ray crystallography study. This analysis revealed that metal (II) complexes remain in distorted tetrahedral coordination environments. The electronic properties such as HOMO and LUMO energies are carried out by gaseous phase DFT/B3LYP calculations using Gaussian 09 program. Complex 1 showed a good binding propensity to the DNA and HSA, during the assessment of docking studies. Schiff base ligand HL and its metal (II) complexes, 1–3 screened for their in vitro antimicrobial activities using the disc diffusion method against selected microbes. Complex 1 shows higher antimicrobial activity than complexes 2, 3 and Schiff base ligand HL. According to the results obtained from the cytotoxic studies, Schiff base ligand HL and its metal (II) complexes 1–3 have better cytotoxicity against MCF‐7 cell lines with potency higher than the currently used chemotherapeutic agent cyclophosphamide.     

Synthesis and catalytic activity of novel heteronuclear Ln (III) -Cu(II) complexes with noncyclic polyether-amino acid Schiff base

A series of novel heteronuclear Ln(III)-CU(II) complexes with noncyclic polyether-amino acid Schiff base were synthesized. The general formula is (LnCu₂(H₂TALY) (NO₃)₅] (NO₃)₂·nH₂O (Ln= La, Nd, Sm, Gd,n = 4; Ln = Yb, Y,n = 3), where H₂TALY = tetraglycol aldehyde bis-lysine Schiff base. It is the first time to report the synthetic method for this new Cu(II) complexes and Ln(III)-Cu(II) heteronuclear complexes. The complexes were characterized by elemental analysis, IR spectra. TG-DTA, magnetic susceptibility, and especially by a 500 MHz NMR spectrometer for 2D-COSY NMR. Coordination mechanism and structures of complexes have been suggested as well. Of particular interest is the potential that the novel complexes obtained may be used as a catalyst. which prompted us to investigate them. It shows 100% conversion with the viscosity-average molecular weight 120 000 for the polymerization of methyl methacrylate (MMA) without addition of any cocatalyst. Furthermore, the complexes with such aliphatic Schiff bases can be used as a good catalyst, which has been confirmed and discussed here. They may be a new kind of catalyst system with the above speciality. Project supported by the National Natural Science Foundation of China (Grant No. 29671026) and Natural Science Foundation of Zhejiang Province (Grant No. 296062) and the Laboratory of MRAMP (Grant No. 971502).     

Crystal structure,DFT study,antimicrobial properties and DNA cleavage potential and thermal behavior of some new mercury complexes

In this study, a new bidentate Schiff base ligand (L) entitled as N,N’-bis(dimethylaminocinnamaldehyde)-2,2-dimethyl-1,3-propanediamine and its mercury complexes were synthesized. The Schiff base ligand and its complexes were characterized using FT-IR, ¹H-, ¹³C-NMR spectroscopy, molar conductivity and electronic spectral study. Regarding physical and spectral data, the general formula for the complexes was suggested as HgLX₂ (L = Schiff base ligand and X = Cl^?, Br^?, I^?, SCN^?, N₃ ^?). For structural identification of these complexes, crystal structure of mercury iodide complex was analyzed as typical one. In the structure of this complex, Hg ion is surrounded by 2 iodide ions and 2 N atoms from the Schiff base ligand to form a four-coordinated mercury complex in triclinic system with space group of P ₁. Angular index (τ ₄) value was evaluated equal to 0.85, so the geometry around the mercury ion in this complex can be described as trigonal pyramid. A layered supramolecular structure for HgLI₂ complex is stabilized by C–H···I and C–H···π interactions in solid state. DFT study on the ligand and its complexes was also carried out, and then some calculated and experimental structural parameters of HgLI₂ were compared. Thermal behaviors of the titled compounds were investigated by thermogravimetric analyses. Furthermore, biological properties of the ligand and its complexes were examined against some Gram-negative and Gram-positive bacteria and also against 2 fungi. Finally, the interaction of the ligand and its complexes with DNA was investigated by electrophoresis method.     

Synthesis and catalytic activity of Ln(III) complexes with an unsymmetrical Schiff base including multi()C = N-groups

A synthetic method for a new unsymmetrical Schiff base and its Ln (III) complexes including multi C == N- groups is reported. The complexes are characterized by elemental analysis, IR spectra, 1H and 13C NMR, especially 2D-COSY1H, 1H NMR spectra. The general formula of the obtained complexes is [Ln3(TBLY)(NO3)3]@nH2O (Ln = La, n = 3; Ln = Nd, n = 5; Ln = Gd, Dy, Yb, Y, n = 7), whereTBLY = tetraglycol aldehyde-2,4-dihydroxy benzaldehyde bis-lysine Schiff base. In addition, the evidence for existence of C == CH-NH- group is supported bythe AM1 method. The complexes obtained may be used as a catalyst. Conversion rate of 80% with the viscosity-average molecular weight 220000 for the polymerization of methyl methacrylate (MMA) without addition of any cocatalyst has been obtained.     

氮杂冠醚化双Schiff碱配合物催化羧酸酯水解的研究

将4种氮杂冠醚取代的双Schiff碱钴(H)、锰(m)配合物作为仿水解酶模型催化羧酸酯(PNPP)水解.考察了Schiff碱配合物中氮杂冠醚取代的位置、氮杂冠醚的数目对其仿水解酶性能的影响;探讨了Schiff配合物催化PNPP水解的动力学和机理;提出了配合物催化PNPP水解的动力学模型.结果表明,在25℃条件下随着缓冲溶液pH值的增大,配合物催化PNPP水解速率提高;四种氮杂冠醚取代的双Schiff碱配合物在催化PNPP水解反应中表现出良好的催化活性;氮杂冠醚3-取代的Schiff碱配合物CoL2的催化活性高于5-取代的Schiff碱配合物CoL1,含有2个氮杂冠醚的配合物CoL3的催化活性高于含有1个氮杂冠醚的配合物CoL2.     

Preparation of nano‐chitosan Schiff‐base copper complexes and their anticancer activity

A new kind of nano‐chitosan Schiff‐base Cu complexes with particle sizes of 350 nm were prepared by combination of nano‐chitosan, Cu and Schiff‐base, and characterized by FT‐IR spectra, TEM, DLS and elemental analysis. The modes and mechanism of interaction of the copper complexes with DNA were studied by the fluorescent probe method and electrophoresis analysis. The results suggest that the Cu complexes bound to DNA by electrostatic and intercalation modes. The anticancer activity of the Cu complexes was evaluated by Sulforhodamine B (SRB) assay in vitro. Nano‐chitosan and their Schiff‐base Cu complexes inhibited the growth of the liver cancer cell lines SMMC‐7721 in vitro. The inhibition rate of Schiff‐base Cu complexes was higher than that of nano‐chitosan. Nano‐chitosan combining with Schiff‐base and Cu improved their anticancer activity, which ascribed to the synergistic effect between the chitosan matrix and the planar construction of the Cu complexes. Copyright © 2008 John Wiley & Sons, Ltd.     

含二茂铁双Schiff碱配体及其Ni(Ⅱ)配合物电子光谱和二阶非线性光学性质的密度泛函理论研究

采用密度泛函理论(DFT)B3LYP方法,对含二茂铁双Schiff碱配体及其Ni(Ⅱ)配合物的几何构型进行优化.在得到稳定构型的基础上,采用含时密度泛函理论(TD-DFT)的B3LYP方法计算了配合物的电子光谱,并结合有限场(FF)方法研究了配体和配合物的极化率和二阶非线性光学(NLO)性质.结果表明,配体中引入Ni(...     

Synthesis and vibrational spectroscopy of halotrichite and bilinite

The new uranyl complexes with tetradentate unsymmetrical N₂O₂ Schiff base ligands were synthesized and characterized by IR, UV–vis, NMR and elemental analysis. The DMF solvent is coordinated to uranyl complexes. The thermogravimetry (TG) and differential thermoanalysis (DTA) of the uranyl complexes were carried out in the range of 20–700 °C. The UO₂L¹ complex was decomposed in two and the others were decomposed in three stages. Up to 100 °C, the coordinated solvent was released then the Schiff base ligands were decomposed in one or two steps. Decomposition of synthesized complexes is related to the Schiff base characteristics. The thermal decomposition reaction is first order for the studied complexes.     

Europium and terbium Schiff base peptide complexes as potential antimicrobial agents against <Emphasis Type="Italic">Salmonella typhimurium</Emphasis> and <Emphasis Type="Italic">Pseudomonas aeruginosa</Emphasis>

Eu(III) and Tb(III) Schiff base complexes are applicable in various fields such as sensing, assays, screening protocols in vitro, and imaging studies in vitro or in vivo. Fluorescent europium and terbium complexes and their interaction with cell penetrating peptide (KKKRKC) can represent an excellent key for understanding pathway of peptide transportation though cell membrane and the application of Schiff base complexes as potential antibacterial drugs. The Schiff base–metal complexes and its conjugates with peptide were tested for their antibacterial activity against Pseudomonas aeruginosa and Salmonella typhimurium. Schiff base–metal complexes conjugated with peptide show minor toxicity in normal human PNT1A cells and high antibacterial activity against P. aeruginosa and S. typhimurium, where IC50 down to 125.9 and/or 36.1 µM were found for P. aeruginosa and S. typhimurium, respectively. Our results strongly suggest that Schiff base–metal complexes conjugated with peptide have great potential to be developed into highly effective antibacterial drug.     

Interaction of water-soluble amino acid Schiff base complexes with bovine serum albumin: fluorescence and circular dichroism studies

Fluorescence spectroscopy in combination with circular dichroism (CD) spectroscopy were used to investigate the interaction of water-soluble amino acid Schiff base complexes, [Zn(L1,2)(phen)] where phen is 1,10-phenanthroline and H2L1,2 is amino acid Schiff base ligands, with bovine serum albumin (BSA) under the physiological conditions in phosphate buffer solution adjusted to pH 7.0. The quenching mechanism of fluorescence was suggested as static quenching according to the Stern-Volmer equation. Quenching constants were determined using the Stern-Volmer equation to provide a measure of the binding affinity between amino acid Schiff base complexes and BSA. The thermodynamic parameters DeltaG, DeltaH and DeltaS at different temperatures (298, 310 and 318K) were calculated. The results indicate that the hydrophobic and hydrogen bonding interactions play a major role in [Zn(L1)(phen)]-BSA association, whereas hydrophobic and electrostatic interactions participate a main role in [Zn(L2)(phen)]-BSA binding process. Binding studies concerning the number of binding sites and apparent binding constant Kb were performed by fluorescence quenching method. The distance R between the donor (BSA) and acceptor (amino acid Schiff base complexes) has been obtained utilizing fluorescence resonant energy transfer (FRET). Furthermore, CD spectra were used to investigate the structural changes of the BSA molecule with the addition of amino acid Schiff base complexes. The results indicate that the interaction of amino acid Schiff base complexes with BSA leads to changes in the secondary structure of the protein. Fractional contents of the secondary structure of BSA (f(alpha), f(beta), f(turn) and f(random)) were calculated with and without amino acid Schiff base complexes utilizing circular dichroism spectroscopy. Our results clarified that amino acid Schiff base complexes could bind to BSA and be effectively transported and eliminated in the body, which could be a useful guideline for further drug design.